Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS

Fighting cancer with next generation oncolytic immunotherapy in ovarian, head & neck, and lung cancers (Immune Checkpoint Response Enabling Adenovirus Technology )

Deliverables

Interim clinical data from at least 3 patients

Deliverable relates to reporting of interim results of the ongoing clinical studies T115 T215

First-patients treated

Update on the trial progress in the first study sites in Docrates finland and Mayo Clinic Minnesota

IND/clinical trial approved (T776)

IND approved for T776 headneck cancer clinical trial

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available